Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.1 USD | -3.23% | -16.49% | -0.37% |
Jun. 01 | Transcript : Iovance Biotherapeutics, Inc. - Special Call | |
May. 13 | Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.37% | 2.34B | |
-41.39% | 8.27B | |
+3.25% | 3.35B | |
-19.19% | 2.02B | |
-22.57% | 1.62B | |
+32.82% | 1.16B | |
-8.30% | 713M | |
+14.12% | 696M | |
-31.22% | 488M | |
-4.97% | 274M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says